Samsara Bio Capital, LLC Surrozen, Inc. Transaction History

Samsara Bio Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.72 $165,000 - $216,000	-300,000 Closed	0 $0
Q1 2023 May 15, 2023	BUY	$0.56 - $1.32 $168,000 - $396,000	300,000 New	300,000 $180,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $12.03 $2.09 Million - $3.61 Million	300,000 New	300,000 $2.12 Million

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $358M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.